Equity Analysis /
United States of America

US : PLx Pharma Inc. - PLXP | 2Q22 Financials: Rating Under Review Following Announcement Seeking Strategic Alternatives

    Michael Parolari
    Michael Parolari

    Research Associate

    Follow
    CGS-CIMB
    15 August 2022
    Published byCGS-CIMB